Noah from United Kingdom

Registered at the short selling broker eToro, 2 minutes ago.

» Try eToro you too
67% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

GlaxoSmithKline Plc (GSK) shares information

GSK Plc – ADR


24h Change

-0.70 %

GSK

Live rate:

Stock data per Monday 8 Aug, 2022

GSK
NEW YORK STOCK EXCHANGE INC.
40.57
40.56
40.29
-0.285 (-0.70%)
US Market is open

Live Stock price in graph for GSK Plc – ADR (GSK)

Data updated continously for GSK, showing up to the 500 most recent 100 data points

  • Latest Volume

    1,771,723 (-53.63 %)

  • Volume prev. day

    3,820,916

  • Avg. daily volume

    4,245,449

  • Market cap

    81,926,639,191

  • P/E ratio

    16.51

  • Today high

    40.656 USD

  • Today low

    40.18 USD

  • 52 week high

    58.24 USD

  • 52 week low

    40.07 USD

  • YTD Change

    n/a

Quick links

 

Latest news about GSK Plc – ADR

Below you can find the most recent news posts about GSK Plc – ADR, primarily from US and UK based news sources.

GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide

Monday, 8 August 2022, 16:42:00
GSK plc (LSE/NYSE: GSK) today announced the launch of Vaccine Track, a comprehensive platform developed by GSK and IQVIA for use by public health officials, industry leaders and medical professionals to strengthen vaccination data transparency, raise awareness and publicly share vaccination trends to aid improvements in routine adult vaccinations to create healthier communities across the US. This
— Wallstreet:Online


Christopher Gent fined £80,000 by FCA for disclosing inside information

Friday, 5 August 2022, 13:05:04
UK regulator rules that businessman breached fiduciary duties by sharing ConvaTec information Sir Christopher Gent, the former chief executive of Vodafone and ex-chair of GlaxoSmithKline, has been fined £80,000 by the UK financial watchdog for disclosing inside information to shareholders while chair of the medical-devices maker ConvaTec. The Financial Conduct Authority (FCA) has fined Gent, one of the most prominent figures in British business, after ruling that he shared information relating to a revision of the financial performance of ConvaTec and plans for the retirement of its chief executive to senior individuals at two of the London-listed company’s biggest shareholders. Continue reading…
— The Guardian


UK watchdog fines veteran businessman Gent 80,000 pounds

Friday, 5 August 2022, 11:53:59
LONDON — Britain’s financial watchdog said on Friday it has fined Christopher Gent 80,000 pounds ($97,104) for unlawfully disclosing inside information in 2018 when he was non-executive chairman of medical technology company ConvaTec. A former CEO of Vodafone and former non-executive chairman of GlaxoSmithKline, the Financial Conduct Authority (FCA) said Gent disclosed information about an […]
— Financial Post


GSK plc – Consensus Indicates Potential 47.6% Upside

Wednesday, 3 August 2022, 12:47:13
GSK plc found using ticker (GSK) have now 3 analysts in total covering the stock. The consensus rating is ”Buy”. The range between the high target price and low target price is between 63.75 and 57.42 with a mean TP of 61.43. Now with the previous closing price of 41.63 this is indicating there is a potential upside of 47.6%. There is a 50 day moving average of 42.89 while the 200 day moving average is 43.85. The market capitalisation for the company is $84,612m. Visit the company website at: https://www.gsk.com [stock_market_widget type=”chart” template=”basic” color=”green” assets=”GSK” range=”6mo” interval=”1d” axes=”true” cursor=”true” api=”yf”] The potential market cap would be $124,855m based on the market concensus. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
— DirectorsTalk


GSK offers to buy back exchangeable senior notes

Wednesday, 3 August 2022, 10:25:56
GSK (GSK) said its unit GSK Finance is offering to buy back for cash any and all of its outstanding exchangeable senior notes due 2023.As of Aug
— Seeking Alpha


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have GSK available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.